| Literature DB >> 25215173 |
Zhe Fan1, Huirong Jing2, Jihong Yao3, Yang Li4, Xiaowei Hu3, Huizhu Shao3, Gang Shen5, Jiyong Pan1, Fuwen Luo2, Xiaofeng Tian2.
Abstract
OBJECTIVE: In this study, we investigated the protective effect and mechanism of curcumin on a rat model of intestinal ischemia/reperfusion (I/R), which induces an acute liver lesion.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25215173 PMCID: PMC4158106 DOI: 10.1155/2014/191624
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Under light microscopy at 200x magnification, histologic injury scores in groups were quantified. Results are presented as the mean ± SD, n = 8. *P < 0.01 versus sham groups; # P < 0.01 versus I/R groups.
Figure 2Curcumin treatment improved liver dysfunction induced by intestinal I/R. (a) AST and (b) ALT levels in different groups (mean ± SD, n = 8). *P < 0.01 versus sham groups; # P < 0.01 versus I/R groups.
Figure 3Curcumin treatment restored SOD but decreased MPO levels in liver after intestinal I/R. (a) SOD and (b) MPO levels in different groups (mean ± SD, n = 8). *P < 0.01 versus sham groups; # P < 0.01 versus I/R groups.
Figure 4Curcumin treatment decreased serum proinflammatory levels after intestinal I/R. (a) TNF-α and (b) IL-6 levels in different groups (mean ± SD, n = 8). *P < 0.01 versus sham groups; # P < 0.01 versus I/R groups.
Figure 5Curcumin treatment decreased ICAM-1 levels after intestinal I/R in different groups (mean ± SD, n = 8). *P < 0.01 versus sham groups; # P < 0.01 versus I/R groups.
Figure 6Curcumin treatment decreased NF-κB levels after intestinal I/R in different groups (mean ± SD, n = 8). *P < 0.01 versus sham groups; # P < 0.01 versus I/R groups.